Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1970)
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
7,500
Price
$217.28
Total Value
$1.63M
Shares Held After
882,351
% of Holdings
0.8%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
399
Price
$366.56
Total Value
$146.26K
Shares Held After
1,302,145
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
826
Price
$365.41
Total Value
$301.83K
Shares Held After
1,302,544
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,329
Price
$364.48
Total Value
$484.39K
Shares Held After
1,303,370
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
565
Price
$363.34
Total Value
$205.29K
Shares Held After
1,304,699
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,992
Price
$362.65
Total Value
$722.40K
Shares Held After
1,305,264
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,242
Price
$361.61
Total Value
$449.12K
Shares Held After
1,307,256
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,320
Price
$360.47
Total Value
$836.28K
Shares Held After
1,308,498
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,392
Price
$359.39
Total Value
$1.22M
Shares Held After
1,310,818
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,180
Price
$358.42
Total Value
$1.14M
Shares Held After
1,314,210
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,962
Price
$357.57
Total Value
$1.42M
Shares Held After
1,317,390
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,267
Price
$356.37
Total Value
$1.16M
Shares Held After
1,321,352
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,006
Price
$355.57
Total Value
$713.28K
Shares Held After
1,324,619
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
520
Price
$354.54
Total Value
$184.36K
Shares Held After
1,326,625
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
405
Price
$366.56
Total Value
$148.46K
Shares Held After
1,347,543
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
847
Price
$365.42
Total Value
$309.51K
Shares Held After
1,347,948
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
1,358
Price
$364.48
Total Value
$494.96K
Shares Held After
1,348,795
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
573
Price
$363.34
Total Value
$208.20K
Shares Held After
1,350,153
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,010
Price
$362.65
Total Value
$728.93K
Shares Held After
1,350,726
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
1,214
Price
$361.61
Total Value
$438.99K
Shares Held After
1,352,736
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,266
Price
$360.46
Total Value
$816.81K
Shares Held After
1,353,950
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,357
Price
$359.39
Total Value
$1.21M
Shares Held After
1,356,216
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,143
Price
$358.42
Total Value
$1.13M
Shares Held After
1,359,573
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,981
Price
$357.57
Total Value
$1.42M
Shares Held After
1,362,716
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,297
Price
$356.37
Total Value
$1.17M
Shares Held After
1,366,697
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,029
Price
$355.57
Total Value
$721.46K
Shares Held After
1,369,994
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
520
Price
$354.54
Total Value
$184.36K
Shares Held After
1,372,023
% of Holdings
0.0%
Atara Biotherapeutics, Inc. (ATRA)
Cherry Brian N — Director
Shares
104,166
Price
$9.60
Total Value
$999.99K
Shares Held After
166,486
% of Holdings
62.6%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
2,137
Price
$117.57
Total Value
$251.25K
Shares Held After
50,254
% of Holdings
4.1%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
3,025
Price
$116.81
Total Value
$353.35K
Shares Held After
52,391
% of Holdings
5.5%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
1,209
Price
$115.55
Total Value
$139.70K
Shares Held After
55,416
% of Holdings
2.1%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
3,625
Price
$2.51
Total Value
$9.09K
Shares Held After
106,015
% of Holdings
3.3%
Caris Life Sciences, Inc. (CAI)
Spetzler David Baxley — President
Shares
119,212
Price
$24.76
Total Value
$2.95M
Shares Held After
1,182,871
% of Holdings
9.2%
Shares
9,800
Price
$0.05
Total Value
$479.22
Shares Held After
9,397,056
% of Holdings
0.1%
Jushi Holdings Inc. (JUSH)
Arsenault Denis J. — 10% Owner
Shares
118,034
Price
$0.59
Total Value
$69.64K
Shares Held After
7,795,933
% of Holdings
1.5%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$11.78
Total Value
$1.18M
Shares Held After
4,171,252
% of Holdings
2.4%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
3,223
Price
$6.07
Total Value
$19.56K
Shares Held After
630,644
% of Holdings
0.5%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
2,877
Price
$6.07
Total Value
$17.46K
Shares Held After
562,715
% of Holdings
0.5%
10x Genomics, Inc. (TXG)
STUELPNAGEL JOHN R — Director
Shares
6,174
Price
$62.61
Total Value
$386.53K
Shares Held After
328,436
% of Holdings
1.8%
10x Genomics, Inc. (TXG)
STUELPNAGEL JOHN R — Director
Shares
6,814
Price
$62.11
Total Value
$423.21K
Shares Held After
334,610
% of Holdings
2.0%
10x Genomics, Inc. (TXG)
STUELPNAGEL JOHN R — Director
Shares
7,012
Price
$60.66
Total Value
$425.33K
Shares Held After
341,424
% of Holdings
2.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
400
Price
$288.98
Total Value
$115.59K
Shares Held After
36,514
% of Holdings
1.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
385
Price
$287.53
Total Value
$110.70K
Shares Held After
36,914
% of Holdings
1.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
2,115
Price
$286.36
Total Value
$605.65K
Shares Held After
37,299
% of Holdings
5.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,800
Price
$285.17
Total Value
$513.30K
Shares Held After
39,414
% of Holdings
4.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
300
Price
$283.99
Total Value
$85.20K
Shares Held After
41,214
% of Holdings
0.7%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
900,000
Price
$1.78
Total Value
$1.60M
Shares Held After
6,524,151
% of Holdings
13.8%
Oscar Health, Inc. (OSCR)
Baltrus Victoria — Chief Accounting Officer
Shares
958
Price
$31.45
Total Value
$30.13K
Shares Held After
213,631
% of Holdings
0.4%
Oscar Health, Inc. (OSCR)
Liang Janet — President, Oscar Insurance
Shares
10,360
Price
$31.45
Total Value
$325.82K
Shares Held After
248,697
% of Holdings
4.0%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
45,000
Price
$102.85
Total Value
$4.63M
Shares Held After
813,209
% of Holdings
5.2%
Showing 401–450 of 1970 transactions (page 9 of 40)